Pfizer Tops Sales Estimates as Older Blockbusters Outperform

Pfizer Inc. reported first quarter sales that beat estimates as demand for older blockbusters helped to offset a decline in revenues from Covid products.

Quarterly sales were $14.5 billion, it said in a statement Tuesday. That topped the average Wall Street estimate of $13.8 billion, as its blood thinner Eliquis and cancer drug Padcev drove demand. Adjusted earnings in the quarter were 75 cents a share, beating analysts’ projection of 73 cents a share.